Experience with tofacitinib in the treatment of resistant rheumatoid arthritis
The Russian Federation has not got sufficient experience with tofacitinib (TOFA) in patients with rheumatoid arthritis (RA) so far; in this connection, all follow-ups using this drug in real clinical practice are of particular interest.Objective: to evaluate the efficancy and safety of TOFA in an op...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
IMA-PRESS LLC
2015-06-01
|
| Serija: | Современная ревматология |
| Teme: | |
| Online pristup: | https://mrj.ima-press.net/mrj/article/view/619 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|